Context Therapeutics Inc.
USD2.05
-0.37 (-15.29%)
CEO
Martin A. Lehr
IPO Date
2021-10-20
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.41
Prev. Close
$2.42
Day Low
$2.04
Day High
$2.45
52W Low
$0.54
52W High
$3.62
Market Cap
$0.19B
Volume
0.91M
| 275,000 |
| $2.32 |
| 23 Feb 2026 | Chagin Karen Deborah | Chief Medical Officer | A-Award | Acquired | 290,000 | $2.32 |
| 23 Feb 2026 | Lehr Martin A. | director, officer: Chief Executive Officer | A-Award | Acquired | 815,000 | $2.32 |
| 12 Jun 2025 | Pasternak Andy | director | A-Award | Acquired | 138,900 | $0.65 |
| 12 Jun 2025 | Kantoff Philip W. | director | A-Award | Acquired | 123,500 | $0.65 |
| 12 Jun 2025 | Smith Karen L. | director | A-Award | Acquired | 123,500 | $0.65 |
| 12 Jun 2025 | Stacey Jennifer Evans | director | A-Award | Acquired | 123,500 | $0.65 |
| 12 Jun 2025 | Walker Luke Nathaniel | director | A-Award | Acquired | 123,500 | $0.65 |
| 12 Jun 2025 | West Linda | director | A-Award | Acquired | 123,500 | $0.65 |